TY - GEN
AU - Inc Pacira Pharmaceuticals
A1 - 
C4 - This grey literature reference is included in the Academy�s Literature Collection in keeping with our mission to gather all sources of information on integration.  Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
C5 - Grey Literature; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
CA - 1140 KB
CY - Parsippany, NJ
L3 - 1140 KB
PB - Pacira Pharmaceuticals, Inc.
PP - Parsippany, NJ
PY - 2017
RN - http://www.planagainstpain.com/wp-content/uploads/2017/09/PlanAgainstPain_USND.pdf
T1 - United States For Non-Dependence: An Analysis of the Impact of Opioid Overprescribing in America
TI - United States For Non-Dependence: An Analysis of the Impact of Opioid Overprescribing in America
U1 - Grey Literature; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
U4 - This grey literature reference is included in the Academy�s Literature Collection in keeping with our mission to gather all sources of information on integration.  Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
U5 - http://www.planagainstpain.com/wp-content/uploads/2017/09/PlanAgainstPain_USND.pdf
UR - http://www.planagainstpain.com/wp-content/uploads/2017/09/PlanAgainstPain_USND.pdf
Y1 - 2017
ER -